A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or 'silent' AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient. Hence, there are important unmet clinical and research needs in the evaluation and management of AF patients. The ensuing needs and opportunities for improving the quality of AF care were discussed during the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference in Nice, France, on 22 and 23 January 2015. Here, we report the outcome of this conference, with a focus on (i) learning from our 'neighbours' to improve AF care, (ii) patient-centred approaches to AF management, (iii) structured care of AF patients, (iv) improving the quality of AF treatment, and (v) personalization of AF management. This report ends with a list of priorities for research in AF patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852 · cited 1×
“Hybrid therapy, defined as the use of antiarrhythmic drug therapy more than 3 months following an ablation to reduce symptoms and/or episodes of AF, is a common therapeutic concept in AF patients.(101,102,103) While it is common practice to stop antiarrhythmic drugs a few weeks or months after Table 6 Quality indicato…”
BackgroundCryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Atrial fibrillation in patients with cryptogenic stroke
Gladstone, D. J., Spring, M., Dorian, P., Panzov, V., Thorpe, K. E., Hall, J., Vaid, H., O'Donnell, M., Laupacis, A., Côté, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311376 · Cited by 1,276
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273 · cited 1×
“A broad range of different cellular and molecular mechanisms underlie AF and are modified by environmental factors.(107) – 109”
BackgroundSelf-citationWilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170 · cited 1×
“Hybrid rhythm control therapy It is well recognized that catheter ablation will not completely eliminate AF in many patients.(99,100) It is in this context that we discuss the concept of ‘hybrid therapy’ for AF (ablation plus antiarrhythmic drugs).”
BackgroundSelf-citationLenient versus strict rate control in patients with atrial fibrillation
Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033
Self-citationPathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.028 · Cited by 949
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792
Self-citationAbed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.280521 · Cited by 776
Atrial Remodeling and Atrial Fibrillation
Nattel, S., & Harada, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.555 · Cited by 736
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation
Cosedis Nielsen, J., Johannessen, A., Raatikainen, P., Hindricks, G., Walfridsson, H., Kongstad, O., Pehrson, S., Englund, A., Hartikainen, J., Mortensen, L. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113566 · Cited by 720
Huxley, R. R., Lopez, F. L., Folsom, A. R., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Maclehose, R., Konety, S., & Alonso, A. (2011) · Circulation · doi:10.1161/circulationaha.110.009035 · Cited by 697 · cited 23×
“We recommend research into clinical parameters that can differentiate different ‘aetiologic types’ of AF.”
BackgroundInfluentialSposato, L. A., Cipriano, L. E., Saposnik, G., Vargas, E. R., Riccio, P. M., & Hachinski, V. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70027-x · Cited by 694
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular Block
Cheng, S. (2009) · JAMA · doi:10.1001/jama.2009.888 · Cited by 614
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study
Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015) · Circulation · doi:10.1161/circulationaha.114.014343 · Cited by 605
Kotecha, D., Holmes, J., Krum, H., Altman, D. G., Manzano, L., Cleland, J. G. F., Lip, G. Y. H., Coats, A. J. S., Andersson, B., Kirchhof, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61373-8 · Cited by 579
Self-citationKuramatsu, J. B., Gerner, S. T., Schellinger, P. D., Glahn, J., Endres, M., Sobesky, J., Flechsenhar, J., Neugebauer, H., Jüttler, E., Grau, A., et al. (2015) · JAMA · doi:10.1001/jama.2015.0846 · Cited by 568 · cited 1×
“(9) We recommend high-quality research projects on the research on timing of recommencing oral anticoagulants after bleeding.(148) (10) The best use of left atrial appendage occlusion devices in clinical practice is not well established.”
BackgroundLowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0231 · Cited by 458
Allessie, M. A., de Groot, N. M. S., Houben, R. P. M., Schotten, U., Boersma, E., Smeets, J. L., & Crijns, H. J. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.910125 · Cited by 450
Self-citationHobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437 · cited 1×
“Screening for unknown AF and initiation of anticoagulation has the potential to prevent strokes in patients with undiagnosed AF, but has so far mainly been evaluated in physician offices, where pulse palpation followed by 12-lead electrocardiogram (ECG) recording seems cost-effective for AF screening.(23,54) A recent…”
BackgroundSelf-citationNabauer, M., Gerth, A., Limbourg, T., Schneider, S., Oeff, M., Kirchhof, P., Goette, A., Lewalter, T., Ravens, U., Meinertz, T., et al. (2008) · Europace · doi:10.1093/europace/eun369 · Cited by 427
Self-citationHendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409 · cited 3×
“(2) We recommend a structured follow-up for all anticoagulated AF patients to remind the patient of the need for AF treatment and to increase adherence and persistence to therapy.(11,92,93) (3) Atrial fibrillation patients who suffer a stroke should be acutely managed in specialized stroke units.”
BackgroundKirchhof, P., Ammentorp, B., Darius, H., De Caterina, R., Le Heuzey, J.-Y., Schilling, R. J., Schmitt, J., & Zamorano, J. L. (2014) · EP Europace · doi:10.1093/europace/eut263 · Cited by 404 · cited 1×
“Nonetheless, underuse or premature termination of therapy with oral anticoagulants is still common.(71) – 76 Although non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) are easy to handle and offer the promise of improved efficacy and safety compared with VKA treatment,(2,77) there is still a substantial under…”
BackgroundIncidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients
Wilke, T., Groth, A., Mueller, S., Pfannkuche, M., Verheyen, F., Linder, R., Maywald, U., Bauersachs, R., & Breithardt, G. (2013) · Europace · doi:10.1093/europace/eus333 · Cited by 397
Self-citationKishore, A., Vail, A., Majid, A., Dawson, J., Lees, K. R., Tyrrell, P. J., & Smith, C. J. (2014) · Stroke · doi:10.1161/strokeaha.113.003433 · Cited by 374
Anker, S. D., Agewall, S., Borggrefe, M., Calvert, M., Jaime Caro, J., Cowie, M. R., Ford, I., Paty, J. A., Riley, J. P., Swedberg, K., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu205 · Cited by 362
Self-citationWynn, G. J., Todd, D. M., Webber, M., Bonnett, L., McShane, J., Kirchhof, P., & Gupta, D. (2014) · Europace · doi:10.1093/europace/eut395 · Cited by 254
Self-citationMcManus, D. D., Lee, J., Maitas, O., Esa, N., Pidikiti, R., Carlucci, A., Harrington, J., Mick, E., & Chon, K. H. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.001 · Cited by 253
Lip, G. Y. H., Laroche, C., Ioachim, P. M., Rasmussen, L. H., Vitali-Serdoz, L., Petrescu, L., Darabantiu, D., Crijns, H. J. G. M., Kirchhof, P., Vardas, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu374 · Cited by 237
Self-citationEngdahl, J., Andersson, L., Mirskaya, M., & Rosenqvist, M. (2013) · Circulation · doi:10.1161/circulationaha.112.126656 · Cited by 233
N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.082 · Cited by 231
Grond, M., Jauss, M., Hamann, G., Stark, E., Veltkamp, R., Nabavi, D., Horn, M., Weimar, C., Köhrmann, M., Wachter, R., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001884 · Cited by 229
Self-citationArbelo, E., Brugada, J., Hindricks, G., Maggioni, A. P., Tavazzi, L., Vardas, P., Laroche, C., Anselme, F., Inama, G., Jais, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu001 · Cited by 212
Self-citationClarkesmith, D. E., Pattison, H. M., Lip, G. Y. H., & Lane, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074037 · Cited by 209
Self-citationSinner, M. F., Tucker, N. R., Lunetta, K. L., Ozaki, K., Smith, J. G., Trompet, S., Bis, J. C., Lin, H., Chung, M. K., Nielsen, J. B., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.009892 · Cited by 205
Self-citationClinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal Persistence
Charitos, E. I., Pürerfellner, H., Glotzer, T. V., & Ziegler, P. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.019 · Cited by 188 · cited 1×
“Furthermore, the clinical differentiation between ‘paroxysmal’ and ‘persistent’ AF may be poor, suggesting that this differentiation is not reflecting different biology.(110) Clinical conditions that are associated with AF and AF-related complications may vary substantially by AF aetiology, but will overlap.”
BackgroundKirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176
Self-citationKirchhof, P., Breithardt, G., Camm, A. J., Crijns, H. J., Kuck, K.-H., Vardas, P., & Wegscheider, K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.015 · Cited by 155
Self-citationAronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V., & Levin, L.-Å. (2015) · Europace · doi:10.1093/europace/euv083 · Cited by 154 · cited 1×
“An economic analysis showed that if an AF screen with these devices at a single time point was extended to the population aged 65–84 years, it would be cost-effective for stroke prevention.(59,62)”
BackgroundNovel genetic markers associate with atrial fibrillation risk in Europeans and Japanese
Lubitz, S. A., Lunetta, K. L., Lin, H., Arking, D. E., Trompet, S., Li, G., Krijthe, B. P., Chasman, D. I., Barnard, J., Kleber, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.015 · Cited by 148
Self-citationStewart, S., Ball, J., Horowitz, J. D., Marwick, T. H., Mahadevan, G., Wong, C., Abhayaratna, W. P., Chan, Y. K., Esterman, A., Thompson, D. R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61992-9 · Cited by 147
Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Europace · doi:10.1093/europace/euv233 · Cited by 142 · cited 1×
“However, it is important to gauge the patient’s desire for their degree of involvement in treatment decisions as some patients may prefer the doctor to make treatment recommendations while other prefer shared decision-making.(28)”
BackgroundDarkner, S., Chen, X., Hansen, J., Pehrson, S., Johannessen, A., Nielsen, J. B., & Svendsen, J. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu354 · Cited by 142
Self-citationNovel genetic markers improve measures of atrial fibrillation risk prediction
Everett, B. M., Cook, N. R., Conen, D., Chasman, D. I., Ridker, P. M., & Albert, C. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht033 · Cited by 141 · cited 1×
“In general, every single nucleotide polymorphism (SNP) only carries a small relative risk, but they can be combined to generate more precise information.(125,126) Genetically determined subtypes of AF in the community have not yet been formulated.”
BackgroundKirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace · doi:10.1093/europace/eut232 · Cited by 141
Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., & Houben, R. P. (2014) · Europace · doi:10.1093/europace/euu057 · Cited by 138
Gallego, P., Roldán, V., Marin, F., Gálvez, J., Valdés, M., Vicente, V., & Lip, G. Y. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.023 · Cited by 124 · cited 1×
“This group advocates access to NOACs for all AF patients in need for oral anticoagulation as an initial therapy option.(77,85,89,90) When this is not deemed feasible, clinical estimates for the likelihood to achieve good anticoagulation with VKA could be considered to identify patients who can be treated with VKA.”
BackgroundTada, H., Shiffman, D., Smith, J. G., Sjögren, M., Lubitz, S. A., Ellinor, P. T., Louie, J. Z., Catanese, J. J., Engström, G., Devlin, J. J., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006072 · Cited by 110
Self-citationHendriks, J., Tomini, F., van Asselt, T., Crijns, H., & Vrijhoef, H. (2013) · Europace · doi:10.1093/europace/eut055 · Cited by 100
Self-citationWiesel, J., Arbesfeld, B., & Schechter, D. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.016 · Cited by 80
Putting patient-reported outcomes on the ‘Big Data Road Map’.
Calvert, M., Thwaites, R., Kyte, D., & Devlin, N. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076815579896 · Cited by 52 · cited 1×
“semi-automated, or remote assessment of patients.(31) In the future, these data may be used at an individual level to identify patients with deteriorating symptoms or aggregated to provide a quality measure.”
BackgroundSelf-citationSmith, D. E., Xuereb, C. B., Pattison, H. M., Lip, G. Y., & Lane, D. A. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-21 · Cited by 42
Cited by
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citationStroke prevention in atrial fibrillation
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31257-0 · Cited by 463
Self-citationHeart Failure With Preserved Ejection Fraction and Atrial Fibrillation
Kotecha, D., Lam, C. S. P., Van Veldhuisen, D. J., Van Gelder, I. C., Voors, A. A., & Rienstra, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.048 · Cited by 463
Self-citation
Metadata
- Authors
- Kirchhof, P., Breithardt, G., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Calvert, M., Christoffels, V., Crijns, H., Dobrev, D., Ellinor, P., Fabritz, L., Fetsch, T., Freedman, S. B., Gerth, A., Goette, A., Guasch, E., Hack, G., Haegeli, L., Hatem, S., Haeusler, K. G., Heidbüchel, H., Heinrich-Nols, J., Hidden-Lucet, F., Hindricks, G., Juul-Möller, S., Kääb, S., Kappenberger, L., Kespohl, S., Kotecha, D., Lane, D. A., Leute, A., Lewalter, T., Meyer, R., Mont, L., Münzel, F., Nabauer, M., Nielsen, J. C., Oeff, M., Oldgren, J., Oto, A., Piccini, J. P., Pilmeyer, A., Potpara, T., Ravens, U., Reinecke, H., Rostock, T., Rustige, J., Savelieva, I., Schnabel, R., Schotten, U., Schwichtenberg, L., Sinner, M. F., Steinbeck, G., Stoll, M., Tavazzi, L., Themistoclakis, S., Tse, H. F., Van Gelder, I. C., Vardas, P. E., Varpula, T., Vincent, A., Werring, D., Willems, S., Ziegler, A., Lip, G. Y. H., & Camm, A. J.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-18
- Volume
- 18
- Issue
- 1
- Pages
- 37-50
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2153858333
- Cited by
- 141
- References
- 58
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.